Clinical Trial Update: A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the dose response of NNC0662-0419 in Japanese, Chinese, and non-Asian participants with overweight or obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• NNC0662-0419

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED